Results for tag: "Cancer Drug Target"

The cancer drug target market within the context of oncology drugs is a highly competitive and rapidly evolving field. It involves the development of drugs that target specific molecules or pathways in cancer cells, with the aim of selectively killing cancer cells while leaving healthy cells unharmed. These drugs are typically used in combination with other treatments such as chemotherapy, radiation, and surgery. The cancer drug target market is driven by the increasing prevalence of cancer, the development of new technologies, and the need for more effective treatments. Companies in this market are focused on developing novel drugs and therapies that can improve patient outcomes and reduce the cost of treatment. These companies include major pharmaceutical companies such as Pfizer, Merck, and Novartis, as well as smaller biotechnology companies such as Gilead Sciences, Celgene, and Amgen. Show Less Read more